Global and United States Stereotactic-guided Biopsy Instrument In-Depth Research Report 2017-2022
The report is based on the market historical data from 2012 to 2016 and forecast the market trend from 2017 to 2022.
This report focuses on the U.S. market and presents volume and value of market share by players, by regions, by product type, by consumers and also changes in prices. As an in-depth report, it covers all details inside analysis and opinions in Stereotactic-guided Biopsy Instrument industry.
Major Companies
C. R. Bard, Inc. (U.S.)
Becton, Dickinson and Company (U.S.)
Cook Group Incorporated (U.S.)
Devicor Medical Products, Inc., (Leica Biosystems) (Germany)
Argon Medical Devices (U.S.)
B. Braun Melsungen AG (Germany)
Cardinal Health, Inc. (U.S.)
Olympus Corporation (Japan)
Boston Scientific Corporation (U.S.)
FUJIFILM Holdings Corporation (Japan)
INRAD, Inc. (U.S.)
Medtronic plc (Ireland)
Key Regions
North America
United States
California
Texas
New York
Others
Canada
Latin America
Mexico
Brazil
Argentina
Others
Europe
Germany
United Kingdom
France
Italy
Spain
Russia
Netherland
Others
Asia & Pacific
China
Japan
India
Korea
Australia
Southeast Asia
Indonesia
Thailand
Philippines
Vietnam
Singapore
Malaysia
Others
Africa & Middle East
South Africa
Egypt
Turkey
Saudi Arabia
Iran
Others
Main types of products
Stereotactic-guided Biopsy Instrument Market, byedle-based Biopsy Instruments
Stereotactic-guided Biopsy Instrument Market, bycalization Wires
Stereotactic-guided Biopsy Instrument Market, byocedure Trays
Stereotactic-guided Biopsy Instrument Market, byhers
Stereotactic-guided Biopsy Instrument Market, by Key Consumers
Breast Biopsy
Lung Biopsy
Colorectal Biopsy
Prostate Biopsy
Others
This report focuses on the U.S. market and presents volume and value of market share by players, by regions, by product type, by consumers and also changes in prices. As an in-depth report, it covers all details inside analysis and opinions in Stereotactic-guided Biopsy Instrument industry.
Major Companies
C. R. Bard, Inc. (U.S.)
Becton, Dickinson and Company (U.S.)
Cook Group Incorporated (U.S.)
Devicor Medical Products, Inc., (Leica Biosystems) (Germany)
Argon Medical Devices (U.S.)
B. Braun Melsungen AG (Germany)
Cardinal Health, Inc. (U.S.)
Olympus Corporation (Japan)
Boston Scientific Corporation (U.S.)
FUJIFILM Holdings Corporation (Japan)
INRAD, Inc. (U.S.)
Medtronic plc (Ireland)
Key Regions
North America
United States
California
Texas
New York
Others
Canada
Latin America
Mexico
Brazil
Argentina
Others
Europe
Germany
United Kingdom
France
Italy
Spain
Russia
Netherland
Others
Asia & Pacific
China
Japan
India
Korea
Australia
Southeast Asia
Indonesia
Thailand
Philippines
Vietnam
Singapore
Malaysia
Others
Africa & Middle East
South Africa
Egypt
Turkey
Saudi Arabia
Iran
Others
Main types of products
Stereotactic-guided Biopsy Instrument Market, byedle-based Biopsy Instruments
Stereotactic-guided Biopsy Instrument Market, bycalization Wires
Stereotactic-guided Biopsy Instrument Market, byocedure Trays
Stereotactic-guided Biopsy Instrument Market, byhers
Stereotactic-guided Biopsy Instrument Market, by Key Consumers
Breast Biopsy
Lung Biopsy
Colorectal Biopsy
Prostate Biopsy
Others
CHAPTER ONE GLOBAL STEREOTACTIC-GUIDED BIOPSY INSTRUMENT MARKET OVERVIEW
1.1 Global Stereotactic-guided Biopsy Instrument Market Sales Volume Revenue and Price 2012-2017
1.2 Stereotactic-guided Biopsy Instrument, by dle-based Biopsy Instruments 2012-2017
1.2.1 Global Stereotactic-guided Biopsy Instrument Sales Market Share by dle-based Biopsy Instruments 2012-2017
1.2.2 Global Stereotactic-guided Biopsy Instrument Revenue Market Share by dle-based Biopsy Instruments 2012-2017
1.2.3 Global Stereotactic-guided Biopsy Instrument Price by dle-based Biopsy Instruments 2012-2017
1.2.4
1.2.5
1.3 Stereotactic-guided Biopsy Instrument, by alization Wires 2012-2017
1.3.1 Global Stereotactic-guided Biopsy Instrument Sales Market Share by alization Wires 2012-2017
1.3.2 Global Stereotactic-guided Biopsy Instrument Revenue Market Share by alization Wires 2012-2017
1.3.3 Global Stereotactic-guided Biopsy Instrument Price by alization Wires 2012-2017
1.3.4
1.3.5
1.4 Stereotactic-guided Biopsy Instrument, by cedure Trays 2012-2017
1.4.1 Global Stereotactic-guided Biopsy Instrument Sales Market Share by cedure Trays 2012-2017
1.4.2 Global Stereotactic-guided Biopsy Instrument Revenue Market Share by cedure Trays 2012-2017
1.4.3 Global Stereotactic-guided Biopsy Instrument Price by cedure Trays 2012-2017
1.4.4
1.4.5
1.5 Stereotactic-guided Biopsy Instrument, by ers 2012-2017
1.5.1 Global Stereotactic-guided Biopsy Instrument Sales Market Share by ers 2012-2017
1.5.2 Global Stereotactic-guided Biopsy Instrument Revenue Market Share by ers 2012-2017
1.5.3 Global Stereotactic-guided Biopsy Instrument Price by ers 2012-2017
1.5.4
1.5.5
CHAPTER TWO UNITED STATES STEREOTACTIC-GUIDED BIOPSY INSTRUMENT MARKET OVERVIEW
2.1 United States Stereotactic-guided Biopsy Instrument Market Sales Volume Revenue and Price 2012-2017
2.2 Stereotactic-guided Biopsy Instrument, by dle-based Biopsy Instruments 2012-2017
2.2.1 United States Stereotactic-guided Biopsy Instrument Sales Market Share by dle-based Biopsy Instruments 2012-2017
2.2.2 United States Stereotactic-guided Biopsy Instrument Revenue Market Share by dle-based Biopsy Instruments 2012-2017
2.2.3 United States Stereotactic-guided Biopsy Instrument Price by dle-based Biopsy Instruments 2012-2017
2.2.4
2.2.5
2.3 Stereotactic-guided Biopsy Instrument, by alization Wires 2012-2017
2.3.1 United States Stereotactic-guided Biopsy Instrument Sales Market Share by alization Wires 2012-2017
2.3.2 United States Stereotactic-guided Biopsy Instrument Revenue Market Share by alization Wires 2012-2017
2.3.3 United States Stereotactic-guided Biopsy Instrument Price by alization Wires 2012-2017
2.3.4
2.3.5
2.4 Stereotactic-guided Biopsy Instrument, by cedure Trays 2012-2017
2.4.1 United States Stereotactic-guided Biopsy Instrument Sales Market Share by cedure Trays 2012-2017
2.4.2 United States Stereotactic-guided Biopsy Instrument Revenue Market Share by cedure Trays 2012-2017
2.4.3 United States Stereotactic-guided Biopsy Instrument Price by cedure Trays 2012-2017
2.4.4
2.4.5
2.5 Stereotactic-guided Biopsy Instrument, by ers 2012-2017
2.5.1 United States Stereotactic-guided Biopsy Instrument Sales Market Share by ers 2012-2017
2.5.2 United States Stereotactic-guided Biopsy Instrument Revenue Market Share by ers 2012-2017
2.5.3 United States Stereotactic-guided Biopsy Instrument Price by ers 2012-2017
2.5.4
2.5.5
CHAPTER THREE STEREOTACTIC-GUIDED BIOPSY INSTRUMENT BY REGIONS 2012-2017
3.1 Global Stereotactic-guided Biopsy Instrument Sales Market Share by Regions 2012-2017
3.2 Global Stereotactic-guided Biopsy Instrument Revenue Market Share by Regions 2012-2017
3.3 Global Stereotactic-guided Biopsy Instrument Price by Regions 2012-2017
3.4 North America
3.4.1 United States
3.4.1.1 California
3.4.1.2 Texas
3.4.1.3 New York
3.4.1.4 Others in United States
3.4.2 Canada
3.5 Latin America
3.5.1 Mexico
3.5.2 Brazil
3.5.3 Argentina
3.5.4 Others in Latin America
3.6 Europe
3.6.1 Germany
3.6.2 United Kingdom
3.6.3 France
3.6.4 Italy
3.6.5 Spain
3.6.6 Russia
3.6.7 Netherland
3.6.8 Others in Europe
3.7 Asia & Pacific
3.7.1 China
3.7.2 Japan
3.7.3 India
3.7.4 Korea
3.7.5 Australia
3.7.6 Southeast Asia
3.7.6.1 Indonesia
3.7.6.2 Thailand
3.7.6.3 Philippines
3.7.6.4 Vietnam
3.7.6.5 Singapore
3.7.6.6 Malaysia
3.7.6.7 Others in Southeast Asia
3.8 Africa & Middle East
3.8.1 South Africa
3.8.2 Egypt
3.8.3 Turkey
3.8.4 Saudi Arabia
3.8.5 Iran
3.8.6 Others in Africa & Middle East
CHAPTER FOUR GLOBAL STEREOTACTIC-GUIDED BIOPSY INSTRUMENT BY COMPANIES 2012-2017
4.1 Global Stereotactic-guided Biopsy Instrument Sales Volume Market Share by Companies 2012-2017
4.2 Global Stereotactic-guided Biopsy Instrument Revenue Share by Companies 2012-2017
4.3 Global Top Companies Stereotactic-guided Biopsy Instrument Key Product Model and Market Performance
4.4 Global Top Companies Stereotactic-guided Biopsy Instrument Key Target Consumers and Market Performance
CHAPTER FIVE UNITED STATES STEREOTACTIC-GUIDED BIOPSY INSTRUMENT BY COMPANIES 2012-2017
5.1 United States Stereotactic-guided Biopsy Instrument Sales Volume Market Share by Companies 2012-2017
5.2 United States Stereotactic-guided Biopsy Instrument Revenue Share by Companies 2012-2017
5.3 United States Top Companies Stereotactic-guided Biopsy Instrument Key Product Model and Market Performance
5.4 United States Top Companies Stereotactic-guided Biopsy Instrument Key Target Consumers and Market Performance
CHAPTER SIX GLOBAL STEREOTACTIC-GUIDED BIOPSY INSTRUMENT BY CONSUMER 2012-2017
6.1 Global Stereotactic-guided Biopsy Instrument Sales Market Share by Consumer 2012-2017
6.2 Breast Biopsy
6.3 Lung Biopsy
6.4 Colorectal Biopsy
6.5 Prostate Biopsy
6.6 Others
6.7 Consuming Habit and Preference
CHAPTER SEVEN GLOBAL STEREOTACTIC-GUIDED BIOPSY INSTRUMENT BY CONSUMER 2012-2017
7.1 Global Stereotactic-guided Biopsy Instrument Sales Market Share by Consumer 2012-2017
7.2 Breast Biopsy
7.3 Lung Biopsy
7.4 Colorectal Biopsy
7.5 Prostate Biopsy
7.6 Others
7.7 Consuming Habit and Preference
CHAPTER EIGHT TOP COMPANIES PROFILE
8.1 C. R. Bard, Inc. (U.S.)
8.1.1 C. R. Bard, Inc. (U.S.) Company Details and Competitors
8.1.2 C. R. Bard, Inc. (U.S.) Key Stereotactic-guided Biopsy Instrument Models and Performance
8.1.3 C. R. Bard, Inc. (U.S.) Stereotactic-guided Biopsy Instrument Business SWOT Analysis and Forecast
8.1.4 C. R. Bard, Inc. (U.S.) Stereotactic-guided Biopsy Instrument Sales Volume Revenue Price Cost and Gross Margin
8.2 Becton, Dickinson and Company (U.S.)
8.2.1 Becton, Dickinson and Company (U.S.) Company Details and Competitors
8.2.2 Becton, Dickinson and Company (U.S.) Key Stereotactic-guided Biopsy Instrument Models and Performance
8.2.3 Becton, Dickinson and Company (U.S.) Stereotactic-guided Biopsy Instrument Business SWOT Analysis and Forecast
8.2.4 Becton, Dickinson and Company (U.S.) Stereotactic-guided Biopsy Instrument Sales Volume Revenue Price Cost and Gross Margin
8.3 Cook Group Incorporated (U.S.)
8.3.1 Cook Group Incorporated (U.S.) Company Details and Competitors
8.3.2 Cook Group Incorporated (U.S.) Key Stereotactic-guided Biopsy Instrument Models and Performance
8.3.3 Cook Group Incorporated (U.S.) Stereotactic-guided Biopsy Instrument Business SWOT Analysis and Forecast
8.3.4 Cook Group Incorporated (U.S.) Stereotactic-guided Biopsy Instrument Sales Volume Revenue Price Cost and Gross Margin
8.4 Devicor Medical Products, Inc., (Leica Biosystems) (Germany)
8.4.1 Devicor Medical Products, Inc., (Leica Biosystems) (Germany) Company Details and Competitors
8.4.2 Devicor Medical Products, Inc., (Leica Biosystems) (Germany) Key Stereotactic-guided Biopsy Instrument Models and Performance
8.4.3 Devicor Medical Products, Inc., (Leica Biosystems) (Germany) Stereotactic-guided Biopsy Instrument Business SWOT Analysis and Forecast
8.4.4 Devicor Medical Products, Inc., (Leica Biosystems) (Germany) Stereotactic-guided Biopsy Instrument Sales Volume Revenue Price Cost and Gross Margin
8.5 Argon Medical Devices (U.S.)
8.5.1 Argon Medical Devices (U.S.) Company Details and Competitors
8.5.2 Argon Medical Devices (U.S.) Key Stereotactic-guided Biopsy Instrument Models and Performance
8.5.3 Argon Medical Devices (U.S.) Stereotactic-guided Biopsy Instrument Business SWOT Analysis and Forecast
8.5.4 Argon Medical Devices (U.S.) Stereotactic-guided Biopsy Instrument Sales Volume Revenue Price Cost and Gross Margin
8.6 B. Braun Melsungen AG (Germany)
8.6.1 B. Braun Melsungen AG (Germany) Company Details and Competitors
8.6.2 B. Braun Melsungen AG (Germany) Key Stereotactic-guided Biopsy Instrument Models and Performance
8.6.3 B. Braun Melsungen AG (Germany) Stereotactic-guided Biopsy Instrument Business SWOT Analysis and Forecast
8.6.4 B. Braun Melsungen AG (Germany) Stereotactic-guided Biopsy Instrument Sales Volume Revenue Price Cost and Gross Margin
8.7 Cardinal Health, Inc. (U.S.)
8.7.1 Cardinal Health, Inc. (U.S.) Company Details and Competitors
8.7.2 Cardinal Health, Inc. (U.S.) Key Stereotactic-guided Biopsy Instrument Models and Performance
8.7.3 Cardinal Health, Inc. (U.S.) Stereotactic-guided Biopsy Instrument Business SWOT Analysis and Forecast
8.7.4 Cardinal Health, Inc. (U.S.) Stereotactic-guided Biopsy Instrument Sales Volume Revenue Price Cost and Gross Margin
8.8 Olympus Corporation (Japan)
8.8.1 Olympus Corporation (Japan) Company Details and Competitors
8.8.2 Olympus Corporation (Japan) Key Stereotactic-guided Biopsy Instrument Models and Performance
8.8.3 Olympus Corporation (Japan) Stereotactic-guided Biopsy Instrument Business SWOT Analysis and Forecast
8.8.4 Olympus Corporation (Japan) Stereotactic-guided Biopsy Instrument Sales Volume Revenue Price Cost and Gross Margin
8.9 Boston Scientific Corporation (U.S.)
8.9.1 Boston Scientific Corporation (U.S.) Company Details and Competitors
8.9.2 Boston Scientific Corporation (U.S.) Key Stereotactic-guided Biopsy Instrument Models and Performance
8.9.3 Boston Scientific Corporation (U.S.) Stereotactic-guided Biopsy Instrument Business SWOT Analysis and Forecast
8.9.4 Boston Scientific Corporation (U.S.) Stereotactic-guided Biopsy Instrument Sales Volume Revenue Price Cost and Gross Margin
8.10 FUJIFILM Holdings Corporation (Japan)
8.10.1 FUJIFILM Holdings Corporation (Japan) Company Details and Competitors
8.10.2 FUJIFILM Holdings Corporation (Japan) Key Stereotactic-guided Biopsy Instrument Models and Performance
8.10.3 FUJIFILM Holdings Corporation (Japan) Stereotactic-guided Biopsy Instrument Business SWOT Analysis and Forecast
8.10.4 FUJIFILM Holdings Corporation (Japan) Stereotactic-guided Biopsy Instrument Sales Volume Revenue Price Cost and Gross Margin
8.11 INRAD, Inc. (U.S.)
8.12 Medtronic plc (Ireland)
CHAPTER NINE INDUSTRY CHAIN AND SUPPLY CHAIN
9.1 Stereotactic-guided Biopsy Instrument Industry Chain Structure
9.1.1 R&D
9.1.2 Raw Materials (Components)
9.1.3 Manufacturing Plants
9.1.4 Regional Trading (Import Export and Local Sales)
9.1.5 Online Sales Channel
9.1.6 Offline Channel
9.1.7 End Users
9.2 Stereotactic-guided Biopsy Instrument Manufacturing
9.2.1 Key Components
9.2.2 Assembly Manufacturing
9.3 Consumer Preference
9.4 Behavioral Habits
9.5 Marketing Environment
CHAPTER TEN GLOBAL STEREOTACTIC-GUIDED BIOPSY INSTRUMENT MARKET SIZE (SALES AND REVENUE) FORECAST (2017-2022)
10.1 Global Stereotactic-guided Biopsy Instrument Sales (K Units), Revenue (Million USD) Forecast (2017-2022)
10.2 Global Stereotactic-guided Biopsy Instrument Sales (K Units) Forecast by Regions (2017-2022)
10.3 Global Stereotactic-guided Biopsy Instrument Sales (K Units) Forecast by Application (2017-2022)
10.4 Global Stereotactic-guided Biopsy Instrument Sales (K Units) Forecast by dle-based Biopsy Instruments (2017-2022)
10.5 Global Stereotactic-guided Biopsy Instrument Sales (K Units) Forecast by alization Wires (2017-2022)
10.6 Global Stereotactic-guided Biopsy Instrument Sales (K Units) Forecast by cedure Trays (2017-2022)
10.7 Global Stereotactic-guided Biopsy Instrument Sales (K Units) Forecast by ers (2017-2022)
CHAPTER ELEVEN UNITED STATES STEREOTACTIC-GUIDED BIOPSY INSTRUMENT MARKET SIZE (SALES AND REVENUE) FORECAST (2017-2022)
11.1 United States Stereotactic-guided Biopsy Instrument Sales (K Units), Revenue (Million USD) Forecast (2017-2022)
11.2 United States Stereotactic-guided Biopsy Instrument Sales (K Units) Forecast by Regions (2017-2022)
11.3 United States Stereotactic-guided Biopsy Instrument Sales (K Units) Forecast by Application (2017-2022)
11.4 United States Stereotactic-guided Biopsy Instrument Sales (K Units) Forecast by dle-based Biopsy Instruments (2017-2022)
11.5 United States Stereotactic-guided Biopsy Instrument Sales (K Units) Forecast by alization Wires (2017-2022)
11.6 United States Stereotactic-guided Biopsy Instrument Sales (K Units) Forecast by cedure Trays (2017-2022)
11.7 United States Stereotactic-guided Biopsy Instrument Sales (K Units) Forecast by ers (2017-2022)
CHAPTER TWELVE DEVELOPMENT TREND AND RESEARCH CONCLUSION
12.1 Development Trend
12.2 Research Conclusion
CHAPTER THIRTEEN METHODOLOGY AND DATA SOURCE
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
1.1 Global Stereotactic-guided Biopsy Instrument Market Sales Volume Revenue and Price 2012-2017
1.2 Stereotactic-guided Biopsy Instrument, by dle-based Biopsy Instruments 2012-2017
1.2.1 Global Stereotactic-guided Biopsy Instrument Sales Market Share by dle-based Biopsy Instruments 2012-2017
1.2.2 Global Stereotactic-guided Biopsy Instrument Revenue Market Share by dle-based Biopsy Instruments 2012-2017
1.2.3 Global Stereotactic-guided Biopsy Instrument Price by dle-based Biopsy Instruments 2012-2017
1.2.4
1.2.5
1.3 Stereotactic-guided Biopsy Instrument, by alization Wires 2012-2017
1.3.1 Global Stereotactic-guided Biopsy Instrument Sales Market Share by alization Wires 2012-2017
1.3.2 Global Stereotactic-guided Biopsy Instrument Revenue Market Share by alization Wires 2012-2017
1.3.3 Global Stereotactic-guided Biopsy Instrument Price by alization Wires 2012-2017
1.3.4
1.3.5
1.4 Stereotactic-guided Biopsy Instrument, by cedure Trays 2012-2017
1.4.1 Global Stereotactic-guided Biopsy Instrument Sales Market Share by cedure Trays 2012-2017
1.4.2 Global Stereotactic-guided Biopsy Instrument Revenue Market Share by cedure Trays 2012-2017
1.4.3 Global Stereotactic-guided Biopsy Instrument Price by cedure Trays 2012-2017
1.4.4
1.4.5
1.5 Stereotactic-guided Biopsy Instrument, by ers 2012-2017
1.5.1 Global Stereotactic-guided Biopsy Instrument Sales Market Share by ers 2012-2017
1.5.2 Global Stereotactic-guided Biopsy Instrument Revenue Market Share by ers 2012-2017
1.5.3 Global Stereotactic-guided Biopsy Instrument Price by ers 2012-2017
1.5.4
1.5.5
CHAPTER TWO UNITED STATES STEREOTACTIC-GUIDED BIOPSY INSTRUMENT MARKET OVERVIEW
2.1 United States Stereotactic-guided Biopsy Instrument Market Sales Volume Revenue and Price 2012-2017
2.2 Stereotactic-guided Biopsy Instrument, by dle-based Biopsy Instruments 2012-2017
2.2.1 United States Stereotactic-guided Biopsy Instrument Sales Market Share by dle-based Biopsy Instruments 2012-2017
2.2.2 United States Stereotactic-guided Biopsy Instrument Revenue Market Share by dle-based Biopsy Instruments 2012-2017
2.2.3 United States Stereotactic-guided Biopsy Instrument Price by dle-based Biopsy Instruments 2012-2017
2.2.4
2.2.5
2.3 Stereotactic-guided Biopsy Instrument, by alization Wires 2012-2017
2.3.1 United States Stereotactic-guided Biopsy Instrument Sales Market Share by alization Wires 2012-2017
2.3.2 United States Stereotactic-guided Biopsy Instrument Revenue Market Share by alization Wires 2012-2017
2.3.3 United States Stereotactic-guided Biopsy Instrument Price by alization Wires 2012-2017
2.3.4
2.3.5
2.4 Stereotactic-guided Biopsy Instrument, by cedure Trays 2012-2017
2.4.1 United States Stereotactic-guided Biopsy Instrument Sales Market Share by cedure Trays 2012-2017
2.4.2 United States Stereotactic-guided Biopsy Instrument Revenue Market Share by cedure Trays 2012-2017
2.4.3 United States Stereotactic-guided Biopsy Instrument Price by cedure Trays 2012-2017
2.4.4
2.4.5
2.5 Stereotactic-guided Biopsy Instrument, by ers 2012-2017
2.5.1 United States Stereotactic-guided Biopsy Instrument Sales Market Share by ers 2012-2017
2.5.2 United States Stereotactic-guided Biopsy Instrument Revenue Market Share by ers 2012-2017
2.5.3 United States Stereotactic-guided Biopsy Instrument Price by ers 2012-2017
2.5.4
2.5.5
CHAPTER THREE STEREOTACTIC-GUIDED BIOPSY INSTRUMENT BY REGIONS 2012-2017
3.1 Global Stereotactic-guided Biopsy Instrument Sales Market Share by Regions 2012-2017
3.2 Global Stereotactic-guided Biopsy Instrument Revenue Market Share by Regions 2012-2017
3.3 Global Stereotactic-guided Biopsy Instrument Price by Regions 2012-2017
3.4 North America
3.4.1 United States
3.4.1.1 California
3.4.1.2 Texas
3.4.1.3 New York
3.4.1.4 Others in United States
3.4.2 Canada
3.5 Latin America
3.5.1 Mexico
3.5.2 Brazil
3.5.3 Argentina
3.5.4 Others in Latin America
3.6 Europe
3.6.1 Germany
3.6.2 United Kingdom
3.6.3 France
3.6.4 Italy
3.6.5 Spain
3.6.6 Russia
3.6.7 Netherland
3.6.8 Others in Europe
3.7 Asia & Pacific
3.7.1 China
3.7.2 Japan
3.7.3 India
3.7.4 Korea
3.7.5 Australia
3.7.6 Southeast Asia
3.7.6.1 Indonesia
3.7.6.2 Thailand
3.7.6.3 Philippines
3.7.6.4 Vietnam
3.7.6.5 Singapore
3.7.6.6 Malaysia
3.7.6.7 Others in Southeast Asia
3.8 Africa & Middle East
3.8.1 South Africa
3.8.2 Egypt
3.8.3 Turkey
3.8.4 Saudi Arabia
3.8.5 Iran
3.8.6 Others in Africa & Middle East
CHAPTER FOUR GLOBAL STEREOTACTIC-GUIDED BIOPSY INSTRUMENT BY COMPANIES 2012-2017
4.1 Global Stereotactic-guided Biopsy Instrument Sales Volume Market Share by Companies 2012-2017
4.2 Global Stereotactic-guided Biopsy Instrument Revenue Share by Companies 2012-2017
4.3 Global Top Companies Stereotactic-guided Biopsy Instrument Key Product Model and Market Performance
4.4 Global Top Companies Stereotactic-guided Biopsy Instrument Key Target Consumers and Market Performance
CHAPTER FIVE UNITED STATES STEREOTACTIC-GUIDED BIOPSY INSTRUMENT BY COMPANIES 2012-2017
5.1 United States Stereotactic-guided Biopsy Instrument Sales Volume Market Share by Companies 2012-2017
5.2 United States Stereotactic-guided Biopsy Instrument Revenue Share by Companies 2012-2017
5.3 United States Top Companies Stereotactic-guided Biopsy Instrument Key Product Model and Market Performance
5.4 United States Top Companies Stereotactic-guided Biopsy Instrument Key Target Consumers and Market Performance
CHAPTER SIX GLOBAL STEREOTACTIC-GUIDED BIOPSY INSTRUMENT BY CONSUMER 2012-2017
6.1 Global Stereotactic-guided Biopsy Instrument Sales Market Share by Consumer 2012-2017
6.2 Breast Biopsy
6.3 Lung Biopsy
6.4 Colorectal Biopsy
6.5 Prostate Biopsy
6.6 Others
6.7 Consuming Habit and Preference
CHAPTER SEVEN GLOBAL STEREOTACTIC-GUIDED BIOPSY INSTRUMENT BY CONSUMER 2012-2017
7.1 Global Stereotactic-guided Biopsy Instrument Sales Market Share by Consumer 2012-2017
7.2 Breast Biopsy
7.3 Lung Biopsy
7.4 Colorectal Biopsy
7.5 Prostate Biopsy
7.6 Others
7.7 Consuming Habit and Preference
CHAPTER EIGHT TOP COMPANIES PROFILE
8.1 C. R. Bard, Inc. (U.S.)
8.1.1 C. R. Bard, Inc. (U.S.) Company Details and Competitors
8.1.2 C. R. Bard, Inc. (U.S.) Key Stereotactic-guided Biopsy Instrument Models and Performance
8.1.3 C. R. Bard, Inc. (U.S.) Stereotactic-guided Biopsy Instrument Business SWOT Analysis and Forecast
8.1.4 C. R. Bard, Inc. (U.S.) Stereotactic-guided Biopsy Instrument Sales Volume Revenue Price Cost and Gross Margin
8.2 Becton, Dickinson and Company (U.S.)
8.2.1 Becton, Dickinson and Company (U.S.) Company Details and Competitors
8.2.2 Becton, Dickinson and Company (U.S.) Key Stereotactic-guided Biopsy Instrument Models and Performance
8.2.3 Becton, Dickinson and Company (U.S.) Stereotactic-guided Biopsy Instrument Business SWOT Analysis and Forecast
8.2.4 Becton, Dickinson and Company (U.S.) Stereotactic-guided Biopsy Instrument Sales Volume Revenue Price Cost and Gross Margin
8.3 Cook Group Incorporated (U.S.)
8.3.1 Cook Group Incorporated (U.S.) Company Details and Competitors
8.3.2 Cook Group Incorporated (U.S.) Key Stereotactic-guided Biopsy Instrument Models and Performance
8.3.3 Cook Group Incorporated (U.S.) Stereotactic-guided Biopsy Instrument Business SWOT Analysis and Forecast
8.3.4 Cook Group Incorporated (U.S.) Stereotactic-guided Biopsy Instrument Sales Volume Revenue Price Cost and Gross Margin
8.4 Devicor Medical Products, Inc., (Leica Biosystems) (Germany)
8.4.1 Devicor Medical Products, Inc., (Leica Biosystems) (Germany) Company Details and Competitors
8.4.2 Devicor Medical Products, Inc., (Leica Biosystems) (Germany) Key Stereotactic-guided Biopsy Instrument Models and Performance
8.4.3 Devicor Medical Products, Inc., (Leica Biosystems) (Germany) Stereotactic-guided Biopsy Instrument Business SWOT Analysis and Forecast
8.4.4 Devicor Medical Products, Inc., (Leica Biosystems) (Germany) Stereotactic-guided Biopsy Instrument Sales Volume Revenue Price Cost and Gross Margin
8.5 Argon Medical Devices (U.S.)
8.5.1 Argon Medical Devices (U.S.) Company Details and Competitors
8.5.2 Argon Medical Devices (U.S.) Key Stereotactic-guided Biopsy Instrument Models and Performance
8.5.3 Argon Medical Devices (U.S.) Stereotactic-guided Biopsy Instrument Business SWOT Analysis and Forecast
8.5.4 Argon Medical Devices (U.S.) Stereotactic-guided Biopsy Instrument Sales Volume Revenue Price Cost and Gross Margin
8.6 B. Braun Melsungen AG (Germany)
8.6.1 B. Braun Melsungen AG (Germany) Company Details and Competitors
8.6.2 B. Braun Melsungen AG (Germany) Key Stereotactic-guided Biopsy Instrument Models and Performance
8.6.3 B. Braun Melsungen AG (Germany) Stereotactic-guided Biopsy Instrument Business SWOT Analysis and Forecast
8.6.4 B. Braun Melsungen AG (Germany) Stereotactic-guided Biopsy Instrument Sales Volume Revenue Price Cost and Gross Margin
8.7 Cardinal Health, Inc. (U.S.)
8.7.1 Cardinal Health, Inc. (U.S.) Company Details and Competitors
8.7.2 Cardinal Health, Inc. (U.S.) Key Stereotactic-guided Biopsy Instrument Models and Performance
8.7.3 Cardinal Health, Inc. (U.S.) Stereotactic-guided Biopsy Instrument Business SWOT Analysis and Forecast
8.7.4 Cardinal Health, Inc. (U.S.) Stereotactic-guided Biopsy Instrument Sales Volume Revenue Price Cost and Gross Margin
8.8 Olympus Corporation (Japan)
8.8.1 Olympus Corporation (Japan) Company Details and Competitors
8.8.2 Olympus Corporation (Japan) Key Stereotactic-guided Biopsy Instrument Models and Performance
8.8.3 Olympus Corporation (Japan) Stereotactic-guided Biopsy Instrument Business SWOT Analysis and Forecast
8.8.4 Olympus Corporation (Japan) Stereotactic-guided Biopsy Instrument Sales Volume Revenue Price Cost and Gross Margin
8.9 Boston Scientific Corporation (U.S.)
8.9.1 Boston Scientific Corporation (U.S.) Company Details and Competitors
8.9.2 Boston Scientific Corporation (U.S.) Key Stereotactic-guided Biopsy Instrument Models and Performance
8.9.3 Boston Scientific Corporation (U.S.) Stereotactic-guided Biopsy Instrument Business SWOT Analysis and Forecast
8.9.4 Boston Scientific Corporation (U.S.) Stereotactic-guided Biopsy Instrument Sales Volume Revenue Price Cost and Gross Margin
8.10 FUJIFILM Holdings Corporation (Japan)
8.10.1 FUJIFILM Holdings Corporation (Japan) Company Details and Competitors
8.10.2 FUJIFILM Holdings Corporation (Japan) Key Stereotactic-guided Biopsy Instrument Models and Performance
8.10.3 FUJIFILM Holdings Corporation (Japan) Stereotactic-guided Biopsy Instrument Business SWOT Analysis and Forecast
8.10.4 FUJIFILM Holdings Corporation (Japan) Stereotactic-guided Biopsy Instrument Sales Volume Revenue Price Cost and Gross Margin
8.11 INRAD, Inc. (U.S.)
8.12 Medtronic plc (Ireland)
CHAPTER NINE INDUSTRY CHAIN AND SUPPLY CHAIN
9.1 Stereotactic-guided Biopsy Instrument Industry Chain Structure
9.1.1 R&D
9.1.2 Raw Materials (Components)
9.1.3 Manufacturing Plants
9.1.4 Regional Trading (Import Export and Local Sales)
9.1.5 Online Sales Channel
9.1.6 Offline Channel
9.1.7 End Users
9.2 Stereotactic-guided Biopsy Instrument Manufacturing
9.2.1 Key Components
9.2.2 Assembly Manufacturing
9.3 Consumer Preference
9.4 Behavioral Habits
9.5 Marketing Environment
CHAPTER TEN GLOBAL STEREOTACTIC-GUIDED BIOPSY INSTRUMENT MARKET SIZE (SALES AND REVENUE) FORECAST (2017-2022)
10.1 Global Stereotactic-guided Biopsy Instrument Sales (K Units), Revenue (Million USD) Forecast (2017-2022)
10.2 Global Stereotactic-guided Biopsy Instrument Sales (K Units) Forecast by Regions (2017-2022)
10.3 Global Stereotactic-guided Biopsy Instrument Sales (K Units) Forecast by Application (2017-2022)
10.4 Global Stereotactic-guided Biopsy Instrument Sales (K Units) Forecast by dle-based Biopsy Instruments (2017-2022)
10.5 Global Stereotactic-guided Biopsy Instrument Sales (K Units) Forecast by alization Wires (2017-2022)
10.6 Global Stereotactic-guided Biopsy Instrument Sales (K Units) Forecast by cedure Trays (2017-2022)
10.7 Global Stereotactic-guided Biopsy Instrument Sales (K Units) Forecast by ers (2017-2022)
CHAPTER ELEVEN UNITED STATES STEREOTACTIC-GUIDED BIOPSY INSTRUMENT MARKET SIZE (SALES AND REVENUE) FORECAST (2017-2022)
11.1 United States Stereotactic-guided Biopsy Instrument Sales (K Units), Revenue (Million USD) Forecast (2017-2022)
11.2 United States Stereotactic-guided Biopsy Instrument Sales (K Units) Forecast by Regions (2017-2022)
11.3 United States Stereotactic-guided Biopsy Instrument Sales (K Units) Forecast by Application (2017-2022)
11.4 United States Stereotactic-guided Biopsy Instrument Sales (K Units) Forecast by dle-based Biopsy Instruments (2017-2022)
11.5 United States Stereotactic-guided Biopsy Instrument Sales (K Units) Forecast by alization Wires (2017-2022)
11.6 United States Stereotactic-guided Biopsy Instrument Sales (K Units) Forecast by cedure Trays (2017-2022)
11.7 United States Stereotactic-guided Biopsy Instrument Sales (K Units) Forecast by ers (2017-2022)
CHAPTER TWELVE DEVELOPMENT TREND AND RESEARCH CONCLUSION
12.1 Development Trend
12.2 Research Conclusion
CHAPTER THIRTEEN METHODOLOGY AND DATA SOURCE
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
LIST OF TABLES AND FIGURES
Table Global Stereotactic-guided Biopsy Instrument Sales Volume (K Units), Revenue (Million USD) and Price (USD/Unit)(2012-2017)
Figure Global Stereotactic-guided Biopsy Instrument Revenue (Million
Table Global Stereotactic-guided Biopsy Instrument Sales Volume (K Units), Revenue (Million USD) and Price (USD/Unit)(2012-2017)
Figure Global Stereotactic-guided Biopsy Instrument Revenue (Million
